Pet Parents

Your dog is part of the family

You’re not alone—and there is hope. 

We understand how devastating it is to hear the words “your dog has cancer.” At FidoCure, we’re here to walk this path with you, offering a science-backed, personalized approach to care that’s designed with one goal in mind: giving your dog the best possible chance.

Through the power of precision medicine, we analyze your dog’s tumor DNA to identify the specific genetic changes driving their cancer. This allows us to match your dog with targeted therapies—more precise, less toxic treatments that can lead to longer life and better days.

Thousands of dogs have already benefited, living far beyond expectations. Others are in remission.

With the right treatment, your dog can have more good daysmore tail wags, and more time with the people who love them most—you.

Precision Medicine: A New Era in Canine Cancer Care

For years, canine cancer has been treated with standard chemotherapy and radiation—regardless of tumor type. But now, the same precision medicine used in human oncology is available for dogs. FidoCure uses genomic testing to identify the specific mutations driving your dog’s cancer. Based on these insights, your veterinarian receives a personalized report recommending one or more targeted therapies tailored to your pet’s unique cancer profile. Many treatments can be prescribed by your vet and given at home—making care more effective, personalized, and less stressful for you and your dog. FidoCure brings modern, science-driven cancer care to the pets who mean the world to us.

Comfort & Ease

Medication is administered at home in pill-form, reducing the number of stressful vet visits.

Precision Medicine

Targeted therapies are chosen based on your dog’s specific cancer type.

Legacy

Your dog’s cancer journey helps advance canine cancer care, giving hope to families across the world.

Peace of Mind

Know that you’re giving your dog the best hope for a healthier, happier life.

Precision medicine for dogs is an advanced form of veterinary cancer treatment that uses genomic testing to analyze the DNA of your dog’s tumor. By identifying specific genetic mutations driving the cancer, precision medicine allows veterinarians to recommend targeted therapies designed specifically for your dog’s unique cancer profile. This personalized approach moves beyond the traditional “one-size-fits-all” treatments like standard chemotherapy.  Backed by compelling real‑world data and peer‑reviewed research, precision medicine gives pet parents hope by delivering more effective, compassionate care rooted in cutting-edge science

Choosing precision medicine for your dog’s cancer can significantly improve treatment outcomes and quality of life. With FidoCure’s approach, therapies are matched to your dog’s specific tumour mutations, which can:

  • Extend survival compared to conventional treatment

  • Reduce harmful side effects by avoiding less effective therapies

  • Provide access to cutting-edge science backed by the largest canine cancer dataset in the world

  • Offer safer treatments and improve quality of life for both pets and their families

By personalizing cancer care, precision medicine helps your dog get the right treatment at the right time—based on real data.

FidoCure treats a wide range of canine cancers with precision medicine. Commonly treated cancers include:

  • Hemangiosarcoma

  • Transitional Cell Carcinoma (TCC)

  • Histiocytic Sarcoma

  • Osteosarcoma (Bone Cancer)

  • Other solid tumors and treatment-resistant cancers

FidoCure uses advanced genomic testing to match your dog with targeted therapies based on their unique cancer profile. Treatment is personalized and can address cancers that haven’t responded to standard options. Always consult your veterinarian to see if FidoCure is right for your dog’s specific diagnosis

Yes, FidoCure is scientifically validated—and we’re proud to say that it’s helping real dogs, like yours, every day.

FidoCure’s precision medicine approach is grounded in rigorous science and backed by peer-reviewed research—including three recent studies published in prestigious Nature journals. These publications were developed in collaboration with leading institutions like Stanford University, the Broad Institute of MIT and Harvard, Tufts University, and the University of Georgia College of Veterinary Medicine.

In addition to this academic validation, FidoCure has been used to guide treatment for over 6,000 dogs with cancer. Through our partnership with Fetch AI, we’ve been able to analyze and confirm the real-world effectiveness of our approach at a scale never before seen in veterinary oncology.

We know how overwhelming a cancer diagnosis can be. That’s why we’re committed to bringing the best of science—delivered with compassion—to help your dog live longer and feel better.

Getting started with FidoCure is simple and supportive—just like it should be when your dog is facing cancer.

You begin simply by filling out the form below, and our team will guide you through the next steps.

Or, talk to your veterinarian or veterinary oncologist and ask if FidoCure’s precision medicine platform is right for your dog. We’ll work directly with your care team to arrange genomic testing, identify targeted treatment options, and support you throughout the journey. FidoCure already partners with 1,300+ veterinary clinics and oncology specialists nationwide, and is growing rapidly.

Because when it comes to your dog’s health, you shouldn’t have to navigate it alone.

Share FidoCure Precision Medicine for Canine Cancer with Your Vet

This guide explains how our therapeutic treatment works and is an easy way to get started. FidoCure will work closely with your veterinary team to deliver the best treatment possible for your pet.

Share FidoCure Precision Medicine for Canine Cancer with Your Vet

This guide explains how our therapeutic treatment works and is an easy way to get started. FidoCure will work closely with your veterinary team to deliver the best treatment possible for your pet. Fill out the form below to receive a PDF copy in your email.